Cite
HARVARD Citation
Zheng, C. et al. (2015). Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease. Blood coagulation and fibrinolysis. 26 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zheng, C. et al. (2015). Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease. Blood coagulation and fibrinolysis. 26 (2), p. . [Online].